Discover why starting HIV treatment promptly preserves immune function, prevents transmission, improves quality of life and ...
The Trump administration's decision to pause U.S. foreign aid has "substantially disrupted" supply of HIV treatments in eight ...
Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...
The WHO chief said that regardless of whether Washington reinstates its funding, "other donors will need to step up".
Nearly 85% of the 1.7 million adolescents with HIV live in sub-Saharan Africa, along with half of the nearly 40 million ...
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...
Health and Me on MSN2d
Yearly Jab For HIV Protection Is Now Almost HereA yearly injection such as Lenacapavir could help overcome barriers to PrEP accessibility by increasing its uptake and making ...
Medpage Today on MSN1d
Long-Acting ART Could Prevent More Infant HIV Infections in ZimbabweSAN FRANCISCO -- Providing long-acting (LA) antiretroviral therapy (ART) to breastfeeding women with HIV who face adherence ...
Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...
Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.
A patient told MassLive she was horrified to receive a phone call from her surgeon post-operation saying she should be tested for bloodborne pathogens.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback